S1 Data - by Hao Deng (409186)

Subjects:

Everolimus decreased IgA1 deposits in glomeruli of α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Everolimus decreased mesangial TfR1 expression in α1^KICD89^Tg mice. by Alexandra Cambier (22307216)

Task 1 two-way ANCOVA significant results. by Mucahit Gemici (21519313)

Task 2 one-way ANCOVA significant results. by Mucahit Gemici (21519313)

Data Sheet 1_Bletilla striata polysaccharides ameliorate metabolic-associated fatty liver disease by decreasing the NLRP3 inflammasome and pyroptosis.pdf by Tingting Yu (419018)

The nsP4-Q192L and C483Y mutations decrease the 4′-FlU sensitivity of both replication and transcription. by Peiqi Yin (6533747)

Expression of proteins significantly correlated with stereotypy severity in CD1 Mice (n = 28). by Kendall M. Coden (18516237)

“…Expression of <i><i>Pdgfb</i></i>, <i><i>Riox2</i></i>, <i><i>Parp1</i></i>, <i><i>Snap29</i></i>, <i><i>Map2k6</i></i>, and <i><i>Cxcl9</i></i> increase with severity of stereotypy, whereas expression of <i><i>Vsig2</i></i> decreases with stereotypy severity. …”

Mendelian randomization analyses for the relevance of anti-H. pylori IgG seropositivity with risk of CHD. by Jing Wang (6206297)

Subjects:

Three essential assumptions of the Mendelian randomization study. by Jing Wang (6206297)

Subjects:

Mendelian randomization analysis of the effect of anti-H. pylori IgG seropositivity on coronary heart disease (CHD). by Jing Wang (6206297)

Subjects:

Results data from this Mendelian randomization study. by Jing Wang (6206297)

Subjects:

Associations of anti-H. pylori IgG seropositivity with mediators. by Jing Wang (6206297)

Subjects:

Comparing detector performance against increasing signal to noise ratios. by Bernd Porr (32394)

Obese <i>mMgat2</i> and <i>HuMgat2</i> mice exhibit increased blood and liver lipid levels. by J. Jose Corbalan (22439198)

Subjects:

Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Urbanization in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by Census Regions in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by the Overall population and Sex in the United States. by Zian Zafar Cheema (22446246)

Subjects:

Dilated Cardiomyopathy-related mortality trends from 1999 to 2023, stratified by the Racial groups in the United States. by Zian Zafar Cheema (22446246)

Subjects: